HNGE
Hinge HealthBAI scenario view
RankAlpha Sentiment CodexPost-earnings T+3The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
Primary-source earnings evidence is strong and constructive. The live quote of $88.84 versus the August 6 anchor of $80.08 indicates an approximately 10.9% positive immediate reaction, but precise attribution and post-print analyst revisions remain limited. Social coverage is unavailable, so this remains constructive monitoring rather than a high-conviction re-rating call.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
Q2 revenue rose 53% year over year to $212.8 million, non-GAAP operating margin reached 29%, free cash flow was $99.6 million, and the FY2026 revenue-guidance midpoint increased to $858 million. [#SEC-8K-2026-08-04]
The board approved a $300 million increase to the repurchase program, with transactions structured under Rule 10b-18 requirements. [#8-K-2026-08-04] [#SEC-8K-2026-08-04]
Hinge signed a definitive agreement to acquire Cylinder Health for $105 million in cash, expanding into virtual-first gastrointestinal care alongside its musculoskeletal and migraine programs. [#SEC-8K-2026-08-04]
Recommendation
No formal recommendation provided.

